| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 13 Nov 2026 |
8-K: Regulation FD Disclosure
Disclaimers and Forward-Looking Statements This investor presentation (this "presentation“) and any oral statements made in connection with this presentation are for information purposes only and do not constitute an offer to sell, a sol... |
| 12 Nov 2026 | 10-Q |
| 12 Nov 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
Atlanta, Georgia (November 12, 2026) – Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial re... |
| 10 Nov 2026 | SCHEDULE 13G/A |
| 05 Oct 2026 |
Form 4: Stewart Deborah, SVP, Chief Accounting Officer
Received 75,000 shares as a grant or award |
| 02 Oct 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On October 1, 2026, Steven E. Rodgers, a Class II director of Aveanna Healthcare Holdings Inc. (the "Company"), notified the Company of his decision to resign from the Company's Board of Directors, effective immediately. Mr. Rodgers‘ dec... |
| 09 Sep 2026 | 144 |
| 27 Aug 2026 | 144 |
| 24 Aug 2026 |
Form 4: J.h. Whitney Equity Partners VII, Llc, 10% owner
Sold 12,496,077 shares ($144M) · Sold 2,250,000 shares ($25.9M) |
| 24 Aug 2026 |
Form 4: Williams Robert M Jr, 10% owner
Sold 14,500,002 shares ($167M) · Sold 2,250,000 shares ($25.9M) |
| 24 Aug 2026 |
Form 4: Vigano Paul R, 10% owner
Sold 14,500,002 shares ($167M) · Sold 2,250,000 shares ($25.9M) |
| 24 Aug 2026 |
Form 4: Windley Rodney D, Director
Sold 180,000 shares ($2.07M) |
| 24 Aug 2026 |
Form 4: Shaner Jeff, Chief Executive Officer
Sold 90,000 shares ($1.04M) |
| 24 Aug 2026 |
Form 4: Reisz Edwin C., Chief Administrative Officer
Sold 50,000 shares ($575K) |
| 24 Aug 2026 |
8-K: Other Events
The stockholders named in Schedule II attached hereto (the “Selling Stockholders”) of Aveanna Healthcare Holdings Inc., a Delaware corporation (the “Company”) propose to sell an aggregate of 15,000,000 shares (the “Firm Stock”) of the Co... |
| 24 Aug 2026 | 424B4 |
| 20 Aug 2026 | 424B4 |
| 13 Aug 2026 | 10-Q |
| 13 Aug 2026 |
8-K: Regulation FD Disclosure
Disclaimers and Forward-Looking Statements This investor presentation (this "presentation“) and any oral statements made in connection with this presentation are for information purposes only and do not constitute an offer to sell, a sol... |
Loading...